33
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Discovery, Design, Synthesis, and Application of Nucleoside/Nucleotides

      editorial
      Molecules
      MDPI

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          For decades, nucleosides and nucleotides have formed the cornerstone of antiviral, antiparasitic and anticancer therapeutics and have been used as tools in exploring nucleic acid structure and function. [1,2] This phenomenon is a direct result of their close structural similarity to naturally occurring nucleosides. As such, any changes to their diverse scaffolds can have profound effects. In general, nucleoside and nucleotide analogues target key biological pathways in the replication cycles of many diseases; however, some have also been shown to target human enzymes, which can sometimes result in harmful consequences. In that regard, this Special Issue will focus on some of the leading approaches towards design, synthesis and biological investigations, as well as the various applications for this highly relevant class of compounds. Two of the notable papers included in this Special Issue focused on novel nucleoside scaffolds, for example, Prof. Christian Ducho’s muraymycin nucleoside analogues. [3] His paper highlights successes in using these natural product nucleoside analogues for antibacterial therapies targeting the peptidoglycan synthetic pathway. Another highly unique nucleoside scaffold is the focus of one of the contributions from the Seley-Radtke group. The innovative fleximers have shown potent activity against two coronaviruses - SARS and MERS [4], as well as filoviruses such as Ebola, Sudan and Marburg. [5] Expanding on those results, a focused structure activity relationship study to improve upon the anti-Ebola activity previously noted is reported in this issue. [6] Another well-known nucleoside scaffold, the carbocyclic analogues, were highlighted in a number of the papers in this Special Issue. For example, an excellent contribution from a highly multi-country and multidisciplinary team of investigators including Dr. Anastasia Khandazhinskaya, Robert Buckheit, Profs. Seley-Radtke and Harry de Koning, describes investigations into the antiprotozoan and antibacterial effects of some structurally unique carbocyclic nucleoside analogues. [7] Another paper from the Khandazhinskaya group focuses on some bicyclic pyrrolo- and furano [2,3-d]pyrimidine analogues. [8] A third describes the preparation of some novel cyclobutene nucleoside analogues from the El-Emam laboratories [9], while another from Slita [10] et al. looked at modifying the 1’-position of the carbocyclic scaffold. Their paper on homocarbocyclic nucleoside analogues also investigated a novel optically active sugar containing a bicyclo[2.2.1]heptane fragment. Additional synthetic efforts to make modified nucleosides, in particular, the total synthesis of two well-known 5′-deoxy 7-deaza nucleoside analogues—toyocomycin and sangivamycin—were described in a paper by the Xiao group [11], while the contribution from the Sun group focused on modifying the sugar. Their paper describes the synthesis of a series of UDP-furanoses using a new synthetic route which employs uridine phosphoropiperidate. [12] Aptamers were also a focus for this issue, starting with a computational investigation from Dr. Stacy Wetmore’s group, focused on studying the thrombin-DNA aptamer protein complex using molecular dynamics MD simulations. [13] Their simulations revealed that the chemically-modified base imparted noticeable structural changes to the aptamer without affecting the global conformation. Related to this, the paper from Yang et al. describes another use for dual targeting aptamers in cancer studies. These highly unique bispecific aptamers can potentially serve as a novel strategy for the targeted enhancement of antitumor immune reactions against MUC1-expressing malignancies. [14] Several other papers in this Special Issue described new RNA structural studies, including one from the Xu et al., which is focused on an investigation of nucleoside stabilizers for Z-form RNA. [15] Another excellent paper from Prof. Maria Camarasa’s group describes their efforts towards the design, synthesis and X-ray crystallographic studies of a series of compounds targeting the foot and mouth disease (FMDV) RNA-dependent RNA polymerase. [16] Their results may prove useful in the design of new antivirals against not only FMDV but also other picornaviruses, since all members of this family require uridylylation to initiate the viral RNA synthesis. Another structure study focused on solving issues by studying structure and function with NMR spectroscopy. Nucleic acid structure and dynamic studies by NMR spectroscopy suffer from chemical shift overlap and line broadening, both of which become worse as RNA size increases. In their paper, the Dayie group described the solid phase synthesis of a stable isotope labeled RNA to help elucidate the structure and function using NMR spectroscopy. [17] Finally, Zhou et al. published a report on using sequencing-based molecular markers and to study the Betula alnoides, a special type of birch tree found in many parts of Asia. [18] In summary, an excellent series of papers covering a broad variety of topics were brought together in this Special Issue that focused on the design, synthesis and various applications for nucleoside, nucleotide and nucleic acid analogues. It is our hope that these will provide important information for others working on related projects, and provide the foundation and impetus for future studies.

          Related collections

          Most cited references17

          • Record: found
          • Abstract: found
          • Article: not found

          The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold

          This is the second of two invited articles reviewing the development of nucleoside analogue antiviral drugs, written for a target audience of virologists and other non-chemists, as well as chemists who may not be familiar with the field. As with the first paper, rather than providing a chronological account, we have chosen to examine particular examples of structural modifications made to nucleoside analogues that have proven fruitful as various antiviral, anticancer, and other therapeutics. The first review covered the more common, and in most cases, single modifications to the sugar and base moieties of the nucleoside scaffold. This paper focuses on more recent developments, especially nucleoside analogues that contain more than one modification to the nucleoside scaffold. We hope that these two articles will provide an informative historical perspective of some of the successfully designed analogues, as well as many candidate compounds that encountered obstacles.
            • Record: found
            • Abstract: found
            • Article: not found

            Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity

            Graphical abstract
              • Record: found
              • Abstract: found
              • Article: not found

              Flex-nucleoside analogues – Novel therapeutics against filoviruses

              Graphical abstract

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Molecules
                Molecules
                molecules
                Molecules
                MDPI
                1420-3049
                27 March 2020
                April 2020
                : 25
                : 7
                : 1526
                Affiliations
                University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA; kseley@ 123456umbc.edu ; Tel.: +1-410-455-8684; Fax: +1-410-455-2609
                Author information
                https://orcid.org/0000-0002-0154-3459
                Article
                molecules-25-01526
                10.3390/molecules25071526
                7181063
                32230805
                8d1a07b9-bb95-4d7e-aaae-98c9227f7f7c
                © 2020 by the author.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 13 March 2020
                : 24 March 2020
                Categories
                Editorial

                Comments

                Comment on this article

                Related Documents Log